IMUX Immunic, Inc.
Company Analysis
Latest News
🟢 Immunic, Inc. is trading 9.6% up today amid broad biotech rebound
Immunic, Inc. is trading approximately 9.6% up in after-hours trading at $14.00 amid a broad biotech rebound following a rates-driven selloff. • The stock is...
🔴 Immunic, Inc. is trading 10.3% down today as rising Treasury yields pressure growth and biotech stocks
Immunic, Inc. is trading 10.3% down at $12.95 amid a broad risk-off move following stronger-than-expected U.S. jobs data. • The robust labor market report has...
🔴 Immunic, Inc. is trading 5.4% down today following stronger-than-expected U.S. jobs data
Immunic, Inc. is trading at $13.65 (down 5.4%) following a sharp sell-off in growth and risk assets triggered by a stronger-than-expected U.S. jobs report. •...
🟢 Immunic, Inc. is trading 6% up today with no clear company-specific catalyst found
Immunic, Inc. is trading at $14.97 (+5.65%) on no clear company-specific catalyst following a strong early-session move. • No major clinical updates,...
Immunic Presents Favorable Phase 2 Data for Vidofludimus Calcium in Progressive MS
Immunic, Inc. announced the presentation of additional data from its Phase 2 CALLIPER trial for its lead asset, vidofludimus calcium (IMU-838), in patients...